Intracardiac Thrombosis Due to Antiphospholipid Syndrome
<!--
/* Font Definitions */
@font-face
{font-family:Arial;
panose-1:2 11 6 4 2 2 2 2 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:3 0 0 0 1 0;}
@font-face
{font-family:"MS 明朝";
panose-1:0 0 0 0 0 0 0 0 0 0;
mso-font-charset:128;
mso-generic-font-family:roman;
mso-font-format:other;
mso-font-pitch:fixed;
mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:1;
mso-generic-font-family:roman;
mso-font-format:other;
mso-font-pitch:variable;
mso-font-signature:0 0 0 0 0 0;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:3 0 0 0 1 0;}
@font-face
{font-family:MinionPro-Regular;
panose-1:0 0 0 0 0 0 0 0 0 0;
mso-font-alt:"Minion Pro";
mso-font-charset:77;
mso-generic-font-family:auto;
mso-font-format:other;
mso-font-pitch:auto;
mso-font-signature:3 0 0 0 1 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
p.TemelParagraf, li.TemelParagraf, div.TemelParagraf
{mso-style-name:"\[Temel Paragraf\]";
mso-style-priority:99;
mso-style-unhide:no;
margin:0cm;
margin-bottom:.0001pt;
line-height:120%;
mso-pagination:none;
mso-layout-grid-align:none;
text-autospace:none;
font-size:12.0pt;
font-family:MinionPro-Regular;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-bidi-font-family:MinionPro-Regular;
color:black;
mso-ansi-language:EN-GB;}
.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 90.0pt 72.0pt 90.0pt;
mso-header-margin:36.0pt;
mso-footer-margin:36.0pt;
mso-paper-source:0;}
div.WordSection1
{page:WordSection1;}
-->
Antiphospholipid
syndrome (APS) is an autoimmune disease characterised by arterial and venous
thrombosis. Recurrent thrombosis and pregnancy losses are important in its
diagnosis. Due to the risk of recurrence of thrombosis, long-term anticoagulant
treatment may be required. Here, we present the case of a patient who suffered
from intracardiac thrombosis due to APS. At present, treatment for significant
thrombotic events in patients with APS, such as the aforementioned intracardiac
thrombosis, is generally lifelong.
___
- 1. Soltesz P, Veres K, Lakos G, Kiss E, Muszbek L, Szegedi G. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a restrospective study of 637 patients. Lupus 2003;12:302-7.